UK markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.34-0.73 (-5.59%)
At close: 04:00PM EST
12.34 0.00 (0.00%)
After hours: 06:03PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
Operating expenses
Research development
35,363
13,286
3,793
3,589
Selling general and administrative
18,960
6,709
1,656
1,420
Total operating expenses
46,525
18,674
4,695
5,009
Operating income or loss
-46,525
-18,674
-4,695
-5,009
Interest expense
2
367
346
9
Total other income/expenses net
-
-1,038
-171
-164
Income before tax
-46,216
-19,955
-5,161
-5,097
Income from continuing operations
-46,216
-19,955
-5,161
-5,097
Net income
-46,216
-19,955
-5,161
-5,097
Net income available to common shareholders
-46,252
-19,955
-5,061
-5,097
Basic EPS
-
-1.67
-0.82
-0.82
Diluted EPS
-
-1.67
-0.82
-0.82
Basic average shares
-
11,967
6,187
6,187
Diluted average shares
-
11,967
6,187
6,187
EBITDA
-
-19,588
-4,815
-5,088